Remdesivir Priced At More Than $3,100 For A Course Of Treatment

1 week ago
Gilead Sciences, maker of the antiviral drug remdesivir, has come up with a price for the COVID-19 treatment that was less than some analysts expected.

An experimental COVID-19 medicine that has been shown to shorten the time people with severe illness have to stay in the hospital finally has a price tag that's lower than some analysts expected.

(Image credit: ULRICH PERREY/POOL/AFP via Getty Images)

More

Latest Post

Real Madrid Femenino Subject Of New Docu-Series ‘Un Sueño Real’
Victoria and Melbourne coronavirus cases by region: where are Covid-19 case numbers getting better and worse?
Explaining Minnesota United’s Hot Start: 10 Goals, 16 Shots On Target
Seoul mayor funeral: anger at use of public funds for five-day service
New Zealand mosque shooter dismisses lawyers, will represent himself at sentencing
Life After COVID: The Debt Tsunami That’s About To Hit The World
Salesforce eclipses Oracle in market cap
Coronavirus Victoria: what you need to know about Melbourne's stage 3 lockdown rules
The president banished Jeff Sessions once, now he hopes to deprive him of former Senate seat
Political Director For Ron Paul Quietly Mines Bitcoin And Builds New Blockchain Company


Latest Shop